Edition:
United States

Teva Pharmaceutical Industries Ltd (TEVA.TA)

TEVA.TA on Tel Aviv Stock Exchange

11,650.00ILa
10:23am EDT
Change (% chg)

0.00 (+0.00%)
Prev Close
11,650.00
Open
11,800.00
Day's High
11,850.00
Day's Low
11,640.00
Volume
509,278
Avg. Vol
510,529
52-wk High
21,200.00
52-wk Low
9,940.00

Latest Key Developments (Source: Significant Developments)

U.S. Senator Claire McCaskill opioid investigation expands to include distributors and additional manufacturers‍​
8:30am EDT 

July 27 (Reuters) - Allergan Plc :U.S. Senator Claire McCaskill opioid investigation expands to include distributors and additional manufacturers‍​.U.S. Senator Claire McCaskill - newest requests for documents, information from opioid manufacturers were sent to Mallinckrodt, Endo, Teva, Allergan‍ ​.U.S. Senator Claire McCaskill - request to McKesson, AmerisourceBergen, Cardinal Health Inc focused on their distribution of opioid products.  Full Article

AstraZeneca CEO: proud to lead AZ, no comment on rumours of move to Teva
3:23am EDT 

July 27 (Reuters) - AstraZeneca CEO Pascal Soriot tells reporters::Not commenting on speculation about his position but proud to be CEO of AZ.Looks forward to continuing to lead AZ team.Nothing further to add, following rumours he might be leaving to join Teva.Further company coverage: AZN.L.  Full Article

Teva announces launch of generic vagifem in U.S.
Monday, 24 Jul 2017 02:51pm EDT 

July 24 (Reuters) - Teva Pharmaceutical Industries Ltd ::Teva announces the launch of generic vagifem in the United States.Announced launch of a generic version of vagifem 10 mcg in U.S.​.  Full Article

Teva Pharm denies anti-competitive behavior with Cephalon
Monday, 17 Jul 2017 07:02am EDT 

July 17 (Reuters) - Teva Pharmaceutical Industries Ltd , TEVA.N::Said on Monday it does not believe it entered into "any anti-competitive behavior" with Cephalon..Said it strongly disagrees with the way the European Commission analyses patent settlement in the pharmaceutical sector..Said in a statement that it will cooperate fully with the European authorities in their inquiry..  Full Article

UK Supreme Court confirms ruling on Lilly's patent case
Wednesday, 12 Jul 2017 05:14am EDT 

July 12 (Reuters) - Eli Lilly And Co :UK Supreme Court confirms that products by Actavis would infringe Lilly's patent, dismisses Actavis' cross-appeal.  Full Article

Celltrion and Teva announce FDA acceptance of BLA for CT-P10
Thursday, 29 Jun 2017 08:30am EDT 

June 29 (Reuters) - Teva Pharmaceutical Industries Ltd :Celltrion and teva announce u.s. Fda acceptance of biologics license application for proposed biosimilar to rituxan® (rituximab).Teva pharmaceutical - ‍bla for ct-p10 has been accepted for filing by fda for standard review, with fda regulatory action expected during q1 of 2018​.  Full Article

Wockhardt Bio AG says commercial litigation with Teva settled
Monday, 26 Jun 2017 01:55am EDT 

June 26 (Reuters) - WOCKHARDT BIO AG ::SAID ON SATURDAY WOCKHARDT LIMITED (INDIA) AND ITS SUBSIDIARIES SETTLE WITH TEVA AND ITS AFFILIATE A COMMERCIAL LITIGATION IN THE HIGH COURT, LONDON.UNIT CP PHARMACEUTICALS LIMITED hAS AGREED TO WAIVE ITS CLAIM FOR THE OUTSTANDING TRADE RECEIVABLE OF GBP 20 MN AND ACCORDINGLY DROPPED ITS COUNTERCLAIM FOR THE SAID AMOUNT AND FURTHER PAID A SUM OF GBP 23 MN TO TEVA AND CEPHALON BY WAY OF FULL AND FINAL SETTLEMENT OF TEVA'S CLAIMS.  Full Article

Wockhardt, units settle commercial litigation with Teva Pharma, Cephalon
Thursday, 22 Jun 2017 06:49am EDT 

June 22 (Reuters) - Wockhardt Ltd ::Says co, units settle with teva and its affiliate a commercial litigation in high court, london.Says commercial litigation in relation to supply contract for a drug named trisenox.Says CP has agreed to waive its claim for outstanding trade receivable of GBP 20 mln .CP dropped its counterclaim for GBP 20 mln and further paid a sum of GBP 23 mln to Teva and Cephalon by way of full and final settlement of Teva's claims.  Full Article

Teva Pharmaceuticals USA says recalls one lot of Paliperidone ER tablets
Thursday, 15 Jun 2017 12:00pm EDT 

June 15 (Reuters) - Teva Pharmaceutical Industries Ltd :Teva Pharmaceuticals USA Inc initiated a voluntary recall to retail-level for one lot of paliperidone extended-release tablets, 3mg, 90 count bottles.Teva Pharmaceuticals USA Inc - The lot of paliperidone extended-release tablets, 3mg, 90 count bottles was distributed under Actavis Pharma Inc label.Teva Pharmaceuticals USA Inc says the recall is being carried out due to failing test results for dissolution.Teva Pharmaceuticals USA Inc says it cannot at this time exclude potential for additional tablets to be below specification.Teva - Based on Teva's investigation, likelihood of consuming two or more consecutive doses with affected product is low.Teva - In addition, no post marketing adverse events have been received to date for lack of effectiveness for this recalled lot.Teva says it has issued an urgent drug recall letter to its direct accounts and has made arrangements for impacted product to be returned to inmar.  Full Article

Teva announces exclusive launch of Generic Pataday in the United States
Friday, 9 Jun 2017 08:53am EDT 

June 9 (Reuters) - Teva Pharmaceutical Industries Ltd :Teva announces exclusive launch of Generic Pataday® in the United States.Teva Pharmaceutical Industries Ltd says launch of generic pataday 0.2% in u.s..  Full Article